1,264
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

Achieving high HPV vaccine completion rates in a pediatric clinic population

, ORCID Icon, ORCID Icon, , &
Pages 1562-1569 | Received 13 Jul 2018, Accepted 01 Oct 2018, Published online: 23 Oct 2018

References

  • Castellsagué X, Giuliano AR, Goldstone S, Guevara A, Mogensen O, Palefsky JM, Group T, Shields C, Liu K, Maansson R, et al. Immunogenicity and safety of the 9-valent HPV vaccine in men. Vaccine. 2015;33(48):6892–6901. doi:10.1016/j.vaccine.2015.06.088.
  • Stillo M, Carrillo Santisteve P, Lopalco PL. Safety of human papillomavirus vaccines: a review. Expert Opin Drug Saf. 2015;14(5):697–712. doi:10.1517/14740338.2015.1013532.
  • Gonçalves AK, Cobucci RN, Rodrigues HM, de Melo AG, Giraldo PC. Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review. Braz J Infect Dis. 2014;18(6):651–659. doi:10.1016/j.bjid.2014.02.005.
  • Van Damme P, Olsson SE, Block S, Castellsague X, Gray GE, Herrera T, Huang L-M, Kim DS, Pitisuttithum P, Chen J, et al. Immunogenicity and safety of a 9-valent HPV vaccine. Pediatrics. 2015;136(1):e28–e39. doi:10.1542/peds.2014-3745.
  • Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, Moreira ED, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women. New England J Med. 2015;372(8):711–723. doi:10.1056/NEJMoa1405044.
  • Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882. doi:10.15585/mmwr.mm6633a2.
  • Widdice LE, Hoagland R, Callahan ST, Kahn JA, Harrison CJ, Pahud BA, Frey SE, Berry AA, Kotloff KL, Edwards KM, et al. Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series. Vaccine. 2018;36(11):1491–1499. doi:10.1016/j.vaccine.2017.12.060.
  • Perkins RB, Chigurupati NL, Apte G, Vercruysse J, Wall-Haas C, Rosenquist A, Lee L, Clark JA, Pierre-Joseph N. Why don’t adolescents finish the HPV vaccine series? A qualitative study of parents and providers. Hum Vaccin Immunother. 2016;12(6):1528–1535. doi:10.1080/21645515.2015.1118594.
  • Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013;31(40):4293–4304. doi:10.1016/j.vaccine.2013.07.013.
  • Fu LY, Bonhomme L-A, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine. 2014;32(17):1901–1920. doi:10.1016/j.vaccine.2014.01.091.
  • Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HJ. Strategies for addressing vaccine hesitancy – A systematic review. Vaccine. 2015;33(34):4180–4190. doi:10.1016/j.vaccine.2015.04.040.
  • Ali-Faisal SF, Colella TJ, Medina-Jaudes N, Benz Scott L. The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials. Patient Educ Couns. 2017;100(3):436–448. doi:10.1016/j.pec.2016.10.014.
  • Farmar A-LM, Love-Osborne K, Chichester K, Breslin K, Bronkan K, Hambidge SJ. Achieving high adolescent HPV vaccination coverage. Pediatrics. 2016;138:5. doi:10.1542/peds.2015-2653.
  • Krantz L, Ollberding NJ, Beck AF, Burkhardt MC. Increasing HPV vaccination coverage through provider-based interventions. Clin Pediatr. 2018 Mar;57(3):319–326. doi: 0009922817722014.
  • Krakow M, Beavis A, Cosides O, Rositch AF. Characteristics of adolescents lacking provider-recommended human papillomavirus vaccination. J Adolesc Health. 2017;60(5):619–622. doi:10.1016/j.jadohealth.2016.11.028.
  • Radisic G, Chapman J, Flight I, Wilson C. Factors associated with parents’ attitudes to the HPV vaccination of their adolescent sons: A systematic review. Prev Med. 2017;95:26–37. doi:10.1016/j.ypmed.2016.11.019.
  • Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med. 2015;77:181–185. doi:10.1016/j.ypmed.2015.05.024.
  • Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1673–1679. doi:10.1158/1055-9965.EPI-15-0326.
  • American Academy of Pediatrics. Periodic survey #66: pediatricians’ attitudes and practices surrounding the delivery of immunizations. Communication and Documentation of Vaccine Risks/Benefits 2006; https://www.aap.org/en-us/professional-resources/Research/Pages/PS66_Executive_Summary_PediatriciansAttitudesandPracticesSurroundingtheDeliveryofImmunizationsPart2.aspx. Accessed 2018 Jan 9
  • Hough-Telford C, Kimberlin DW, Aban I, Hitchcock WP, Almquist J, Kratz R, OConnor KG. Vaccine delays, refusals, and patient dismissals: a survey of pediatricians. Pediatrics. 2016;138:3. doi:10.1542/peds.2016-2127.
  • Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–1046. doi:10.1542/peds.2013-2037.
  • Cheruvu VK, Bhatta MP, Drinkard LN. Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: national Immunization Survey - Teen 2008–2012. BMC Pediatr. 2017;17:52. doi:10.1186/s12887-017-0969-7.
  • Mohammed KA, Vivian E, Loux TM, Arnold LD. Factors Associated With Parents’ Intent to Vaccinate Adolescents for Human Papillomavirus: findings from the 2014 national immunization survey–teen. Prev Chronic Dis. 2017;14:E45. doi:10.5888/pcd14.160314.
  • Jemal A, Simard EP, Dorell C, Noone A-M, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, et al. Annual report to the nation on the status of cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)–associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105(3):175–201. doi:10.1093/jnci/djs491.
  • American Cancer Society. Key statistics for cervical cancer. 2018; https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html. Accessed 2018 Jan 8
  • Zhan FB, Lin Y. Racial/ethnic socioeconomic, and geographic disparities of cervical cancer advanced-stage diagnosis in Texas. Women’s Health Issues. 2014;24(5):519–527. doi:10.1016/j.whi.2014.06.009.
  • Quinn S, Jamison A, Musa D, Hilyard K, Freimuth V. Exploring the continuum of vaccine hesitancy between african american and white adults: results of a qualitative study. PLoS Currents. 2016;8:ecurrents.outbreaks.3e4a5ea39d8620494e8620492a8620492c8620874a8620493c8624201.
  • Katz IT, Bogart LM, Fu CM, Liu Y, Cox JE, Samuels RC, Chase T, Schubert P, Schuster MA. Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Public Health. 2016;16(1):874. doi:10.1186/s12889-016-3529-4.
  • Rutten LJ, St Sauver JL, Beebe TJ, Wilson PM, Jacobson DJ, Fan C, Breitkopf CR, Vadaparampil ST, Jacobson RM. Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: association with initiation and completion rates. Vaccine. 2017;35(1):164–169. doi:10.1016/j.vaccine.2016.11.012.
  • Alexander SC, Fortenberry JD, Pollak KI, Bravender T, Davis JK, Ostbye T, Tulsky JA, Dolor RJ, Shields CG. Sexuality talk during adolescent health maintenance visits. JAMA Pediatr. 2014;168(2):163–169.
  • Berenson AB, Brown VG, Fuchs EL, Hirth JM, Chang M. Relationship between maternal experiences and adolescent HPV vaccination. Hum Vaccin Immunother. 2017;13(9):2150–2154. doi:10.1080/21645515.2017.1332551.
  • Berenson AB, Rahman M, Hirth JM, Rupp RE, Sarpong KO. A brief educational intervention increases providers’ human papillomavirus vaccine knowledge. Hum Vaccin Immunother. 2015;11(6):1331–1336. doi:10.1080/21645515.2015.1022691.
  • Groom HC, Irving SA, Caldwell J, Larsen R, Beaudrault S, Luther LM, Naleway AL. Implementing a multipartner HPV vaccination assessment and feedback intervention in an integrated health system. J Public Health Manag Pract. 2017;23(6):589–592. doi:10.1097/PHH.0000000000000562.
  • Centers for Disease Control and Prevention (CDC). HPV (Human papillomavirus) vaccine: what you need to know. http://www.immunize.org/vis/hpv.pdf. Accessed 2018 Apr 20
  • Centers for Disease Control and Prevention (CDC). Diseases and the vaccines that prevent them: HPV also known as human papillomavirus. https://www.cdc.gov/vaccines/parents/diseases/teen/hpv-indepth-color.pdf. Accessed 2018 Apr 20
  • Centers for Disease Control and Prevention (CDC). What parents should know about HPV vaccine safety and effectiveness. https://www.cdc.gov/vaccines/partners/downloads/teens/vaccine-safety.pdf https://www.cdc.gov/vaccines/parents/diseases/teen/hpv-indepth-color.pdf. Accessed 2018 Apr 20

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.